Lack of Avidity Maturation of Merozoite Antigen-Specific Antibodies with Increasing Exposure to Plasmodium falciparum amongst Children and Adults Exposed to Endemic Malaria in Kenya

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Ibison, Frances ^a,b   Olotu, Ally ^a   Muema, Daniel M ^a   Mwacharo, Jedida ^a   Ohuma, Eric ^a   Kimani, Domtila ^a   Marsh, Kevin ^a,c   Bejon, Philip ^a,c   Ndungu, Francis M ^a,c  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 3; PARASITE ANTIGEN; PROTOZOON ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; FOLLOW UP; HUMAN; IMMUNITY; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MEROZOITE; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PREVALENCE;

ADULT; ANTIBODIES, PROTOZOAN; ANTIBODY AFFINITY; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KENYA; MALARIA; MALE; MEMBRANE PROTEINS; MEROZOITE SURFACE PROTEIN 1; MEROZOITES; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

PLASMODIUM FALCIPARUM;

EID: 84871559953     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052939     Document Type: Article

References (37)

1. Cohen S, Mc GI, Carrington S, (1961) Gamma-globulin and acquired immunity to human malaria. Nature 192: 733-737.
2. McGregor IA, Carrington S, (1963) Treatment of East African P. falciparum malaria with West African human γ-globulin. Trans R Soc Trop Med Hyg 57: 170-175.
3. Sabchareon A, Burnouf T, Ouattara D, Attanath P, Bouharoun-Tayoun H, et al. (1991) Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg 45: 297-308.
4. Fowkes FJ, Richards JS, Simpson JA, Beeson JG, (2010) The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis. PLoS Med 7: e1000218.
5. Moormann AM, (2009) How might infant and paediatric immune responses influence malaria vaccine efficacy? Parasite Immunol 31: 547-559.
6. Bejon P, Warimwe G, Mackintosh CL, Mackinnon MJ, Kinyanjui SM, et al. (2009) Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure. Infect Immun 77: 1917-1923.
7. Corran P, Coleman P, Riley E, Drakeley C, (2007) Serology: a robust indicator of malaria transmission intensity? Trends Parasitol 23: 575-582.
8. Tongren JE, Drakeley CJ, McDonald SL, Reyburn HG, Manjurano A, et al. (2006) Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria. Infect Immun 74: 257-264.
9. Bouharoun-Tayoun H, Oeuvray C, Lunel F, Druilhe P, (1995) Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med 182: 409-418.
10. Osier FH, Fegan G, Polley SD, Murungi L, Verra F, et al. (2008) Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 76: 2240-2248.
11. Hedman K, Lappalainen M, Seppaia I, Makela O, (1989) Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 159: 736-740.
12. Wilson KM, Di Camillo C, Doughty L, Dax EM, (2006) Humoral immune response to primary rubella virus infection. Clin Vaccine Immunol 13: 380-386.
13. Goldblatt D, Vaz AR, Miller E, (1998) Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis 177: 1112-1115.
14. Vermont CL, van Dijken HH, van Limpt CJ, de Groot R, van Alphen L, et al. (2002) Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine. Infect Immun 70: 584-590.
15. Achtman AH, Stephens R, Cadman ET, Harrison V, Langhorne J, (2007) Malaria-specific antibody responses and parasite persistence after infection of mice with Plasmodium chabaudi chabaudi. Parasite Immunol 29: 435-444.
16. Ferreira MU, Kimura EA, De Souza JM, Katzin AM, (1996) The isotype composition and avidity of naturally acquired anti-Plasmodium falciparum antibodies: differential patterns in clinically immune Africans and Amazonian patients. Am J Trop Med Hyg 55: 315-323.
17. Leoratti FM, Durlacher RR, Lacerda MV, Alecrim MG, Ferreira AW, et al. (2008) Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria. Malar J 7: 186.
18. Tutterrow YL, Salanti A, Avril M, Smith JD, Pagano IS, et al. (2012) High Avidity Antibodies to Full-Length VAR2CSA Correlate with Absence of Placental Malaria. PLoS One 7: e40049.
19. Reddy SB, Anders RF, Beeson JG, Farnert A, Kironde F, et al. (2012) High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria. PLoS One 7: e32242.
20. Akpogheneta OJ, Dunyo S, Pinder M, Conway DJ, (2010) Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection. Parasite Immunol 32: 296-304.
21. Olotu A, Fegan G, Wambua J, Nyangweso G, Ogada E, et al. (2012) Estimating individual exposure to malaria using local prevalence of malaria infection in the field. PLoS One 7: e32929.
22. Mwangi TW, Mohammed M, Dayo H, Snow RW, Marsh K, (2005) Clinical algorithms for malaria diagnosis lack utility among people of different age groups. Trop Med Int Health 10: 530-536.
23. Mwangi TW, Ross A, Snow RW, Marsh K, (2005) Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J Infect Dis 191: 1932-1939.
24. O'Meara WP, Noor A, Gatakaa H, Tsofa B, McKenzie FE, et al. (2009) The impact of primary health care on malaria morbidity-defining access by disease burden. Trop Med Int Health 14: 29-35.
25. Okiro EA, Hay SI, Gikandi PW, Sharif SK, Noor AM, et al. (2007) The decline in paediatric malaria admissions on the coast of Kenya. Malar J 6: 151.
26. Bejon P, Mwacharo J, Kai O, Todryk S, Keating S, et al. (2007) The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. J Immunol 179: 4193-4201.
27. Mbogo CM, Mwangangi JM, Nzovu J, Gu W, Yan G, et al. (2003) Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast. Am J Trop Med Hyg 68: 734-742.
28. Polley SD, Conway DJ, Cavanagh DR, McBride JS, Lowe BS, et al. (2006) High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 24: 4233-4246.
29. Polley SD, Mwangi T, Kocken CH, Thomas AW, Dutta S, et al. (2004) Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 23: 718-728.
30. Polley SD, Tetteh KK, Lloyd JM, Akpogheneta OJ, Greenwood BM, et al. (2007) Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. J Infect Dis 195: 279-287.
31. Dorner T, Radbruch A, (2007) Antibodies and B cell memory in viral immunity. Immunity 27: 384-392.
32. Achtman AH, Khan M, MacLennan IC, Langhorne J, (2003) Plasmodium chabaudi chabaudi infection in mice induces strong B cell responses and striking but temporary changes in splenic cell distribution. J Immunol 171: 317-324.
33. Cadman ET, Abdallah AY, Voisine C, Sponaas AM, Corran P, et al. (2008) Alterations of splenic architecture in malaria are induced independently of Toll-like receptors 2, 4, and 9 or MyD88 and may affect antibody affinity. Infect Immun 76: 3924-3931.
34. Stevenson MM, Kraal G, (1989) Histological changes in the spleen and liver of C57BL/6 and A/J mice during Plasmodium chabaudi AS infection. Exp Mol Pathol 51: 80-95.
35. Weiss L, (1989) Mechanisms of splenic control of murine malaria: cellular reactions of the spleen in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice, and the consequences of pre-infective splenectomy. Am J Trop Med Hyg 41: 144-160.
36. Urban BC, Hien TT, Day NP, Phu NH, Roberts R, et al. (2005) Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization. Infect Immun 73: 1986-1994.
37. Ndungu FM, Olotu A, Mwacharo J, Nyonda M, Apfeld J, et al. (2012) Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children. Proc Natl Acad Sci U S A 109: 8247-8252.